Literature DB >> 17031706

Differences in the cellular mechanism underlying the effects of amphetamine on prepulse inhibition in apomorphine-susceptible and apomorphine-unsusceptible rats.

Martine C J van der Elst1, Yvette S Wunderink, Bart A Ellenbroek, Alexander R Cools.   

Abstract

BACKGROUND: Amphetamine is often used to mimic certain aspects of schizophrenia in laboratory animals, such as a decreased prepulse inhibition.
MATERIALS AND METHODS: Apomorphine-susceptible and apomorphine-unsusceptible rats represent a well-characterized animal model for individual differences in the sensitivity to dopaminergic drugs. Moreover, apomorphine-susceptible rats show a wide variety of schizophrenia-like abnormalities. The differential response to administration of amphetamine (1-4 mg/kg, i.p.) was investigated in these two rat lines using the prepulse inhibition paradigm. Because amphetamine promotes dopamine release, the cellular mechanism underlying the line-specific effects of amphetamine was investigated by administration of alpha-methyl-para-tyrosine (aMpT) and reserpine, substances that are known to deplete the cytosolic dopamine pool and the vesicular dopamine pool, respectively, the former being primarily implicated in mediating the effects of amphetamine.
RESULTS: All doses of amphetamine decreased prepulse inhibition in apomorphine-susceptible rats, whereas only the highest doses (2 and 4 mg/kg, i.p.) of amphetamine decreased prepulse inhibition in apomorphine-unsusceptible rats. Alpha-methyl-para-tyrosine, but not reserpine, blocked the amphetamine-induced disruption in prepulse inhibition in apomorphine-unsusceptible rats, whereas both substances alone had no effect in apomorphine-susceptible rats. However, the combination of alpha-methyl-para-tyrosine and reserpine did block the amphetamine-induced effects in the latter rat line. DISCUSSION: The present study suggests that apomorphine-susceptible rats are more sensitive to systemic administration of amphetamine than apomorphine-unsusceptible rats. In addition, the data show that the cellular mechanism underlying the effects of amphetamine differs between apomorphine-susceptible and apomorphine-unsusceptible rats. Whereas the effects of amphetamine on prepulse inhibition in apomorphine-unsusceptible rats just require the alpha-methyl-para-tyrosine sensitive dopamine pool, the effects in apomorphine-susceptible rats require both the alpha-methyl-para-tyrosine sensitive and the reserpine sensitive dopamine pool. Because apomorphine-susceptible rats share many features with schizophrenic patients, these data open the perspective that in these patients amphetamine may induce dopamine release from both types of dopamine pool. This might provide an explanation for the increased dopamine release after this psychostimulant drug in patients vs controls.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17031706     DOI: 10.1007/s00213-006-0587-9

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  36 in total

Review 1.  Radioligands of the vesicular monoamine transporter and their use as markers of monoamine storage vesicles.

Authors:  J P Henry; D Scherman
Journal:  Biochem Pharmacol       Date:  1989-08-01       Impact factor: 5.858

2.  Tyrosine hydroxylase inhibitors.

Authors:  K E Moore; J A Dominic
Journal:  Fed Proc       Date:  1971 May-Jun

3.  The role of genetic and early environmental factors in determining apomorphine susceptibility.

Authors:  B A Ellenbroek; F Sluyter; A R Cools
Journal:  Psychopharmacology (Berl)       Date:  2000-02       Impact factor: 4.530

4.  Gating and habituation of the startle reflex in schizophrenic patients.

Authors:  D L Braff; C Grillon; M A Geyer
Journal:  Arch Gen Psychiatry       Date:  1992-03

5.  Evidence for presynaptic dopamine mechanisms underlying amphetamine-conditioned locomotion.

Authors:  S L DiLullo; M T Martin-Iverson
Journal:  Brain Res       Date:  1992-04-24       Impact factor: 3.252

6.  Antipsychotic potential of CCK-based treatments: an assessment using the prepulse inhibition model of psychosis.

Authors:  D Feifel; T Reza; S Robeck
Journal:  Neuropsychopharmacology       Date:  1999-02       Impact factor: 7.853

7.  Involvement of intraterminal dopamine compartments in the amine release in the cat striatum.

Authors:  V Leviel; B Guibert
Journal:  Neurosci Lett       Date:  1987-05-06       Impact factor: 3.046

8.  Effects of reserpine on extracellular caudate dopamine and hippocampus norepinephrine responses to amphetamine and cocaine: mechanistic and behavioral considerations.

Authors:  S M Florin; R Kuczenski; D S Segal
Journal:  J Pharmacol Exp Ther       Date:  1995-07       Impact factor: 4.030

9.  The reserpine-sensitive dopamine pool mediates (+)-amphetamine-conditioned reward in the place preference paradigm.

Authors:  N Hiroi; N M White
Journal:  Brain Res       Date:  1990-02-26       Impact factor: 3.252

10.  Reserpine inhibits amphetamine action in ventral midbrain culture.

Authors:  D Sulzer; C St Remy; S Rayport
Journal:  Mol Pharmacol       Date:  1996-02       Impact factor: 4.436

View more
  2 in total

Review 1.  Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Authors:  Neal R Swerdlow; Martin Weber; Ying Qu; Gregory A Light; David L Braff
Journal:  Psychopharmacology (Berl)       Date:  2008-06-21       Impact factor: 4.530

2.  Maternal care affects the phenotype of a rat model for schizophrenia.

Authors:  Ruben W M van Vugt; Francisca Meyer; Josephus A van Hulten; Jeroen Vernooij; Alexander R Cools; Michel M M Verheij; Gerard J M Martens
Journal:  Front Behav Neurosci       Date:  2014-08-11       Impact factor: 3.558

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.